title: [Genetic basis of head and neck cancers and gene therapy].
abstract: Surgery and combinations of traditional treatments are not successful enough particularly for advanced stage head and neck cancer. The major disadvantages of chemotherapy and radiation therapy are the lack of specificity for the target tissue and toxicity to the patient. As a result, gene therapy may offer a more specific approach. The aim of gene therapy is to present therapeutic genes into cancer cells which selectively eliminate malignant cells with no systemic toxicity to the patient. This article reviews the genetic basis of head and neck cancers and important concepts in cancer gene therapy: (i) inhibition of oncogenes; (ii) tumor suppressor gene replacement; (iii) regulation of immune response against malignant cells; (iv) genetic prodrug activation; and (v) antiangiogenic gene therapy. Currently, gene therapy is not sufficient to replace the traditional treatments of head and neck cancers, however there is no doubt that it will have an important role in the near future.
authors.affiliation: Department of Otolaryngology, Medicine Faculty of Bozok University, 66200 Yozgat, Turkey. heozel@yahoo.com
authors.forename: Halil Erdem
authors.initials: HE
authors.lastname: Özel
authors.forename: Mahmut
authors.initials: M
authors.lastname: Özkırış
authors.forename: Zeliha Kapusuz
authors.initials: ZK
authors.lastname: Gencer
authors.forename: Levent
authors.initials: L
authors.lastname: Saydam
mesh_terms: D015316:Genetic Therapy / Q000379:methods / Q000592:standards / Q000639:trends; D006258:Head and Neck Neoplasms / Q000235:genetics* / Q000628:therapy*; D006801:Humans